DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) — all Canadian products
8 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02468891 | APO-DABIGATRAN | APOTEX INC | Capsule | Oral | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MG | Marketed | |
| 02468913 | APO-DABIGATRAN | APOTEX INC | Capsule | Oral | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MG | Marketed | |
| 02468905 | APO-DABIGATRAN | APOTEX INC | Capsule | Oral | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 110 MG | Marketed | |
| 02312441 | PRADAXA | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Capsule | Oral | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 110 MG | Marketed | |
| 02358808 | PRADAXA | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Capsule | Oral | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MG | Marketed | |
| 02312433 | PRADAXA | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Capsule | Oral | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MG | Cancelled Post Market | |
| 02463466 | TEVA-DABIGATRAN | TEVA CANADA LIMITED | Capsule | Oral | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MG | Cancelled Pre Market | |
| 02463458 | TEVA-DABIGATRAN | TEVA CANADA LIMITED | Capsule | Oral | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MG | Cancelled Pre Market |
Browse other molecules: